Prognosis of octogenarians with severe aortic valve stenosis at high risk for cardiovascular surgery

Heart

Volumn 96, Issue 22, 2010, Pages 1831-1836

  Schueler, Robert ^a   Hammerstingl, Christoph ^a   Sinning, Jan Malte ^a   Nickenig, Georg ^a   Omran, Heyder ^b  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b ST MARIEN HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

AGED; AORTA VALVE STENOSIS; ARTICLE; CARDIOVASCULAR SURGERY; FEMALE; HEART EJECTION FRACTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURVIVAL;

AGED; AGED, 80 AND OVER; AORTIC VALVE STENOSIS; COMORBIDITY; ECHOCARDIOGRAPHY, DOPPLER; EPIDEMIOLOGIC METHODS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; MALE; PROGNOSIS; TREATMENT OUTCOME;

EID: 78349309919     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/hrt.2010.202663     Document Type: Article

References (23)

1. Lindroos M, Kupari M, Heikkila J, et al. Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993;21:1220-5.
2. Supino PG, Borer JS, Yin A, et al. The epidemiology of valvular heart diseases: the problem is growing. Adv Cardiol 2004;41:9-15.
3. Frank S, Johnson A, Ross J Jr. Natural history of valvular aortic stenosis. Br Heart J 1973;35:41-6.
4. Ross J Jr, Braunwald E. Aortic stenosis. Circulation 1968;38(1 Suppl):61-7.
5. Bonow RO, Carabello BA, Chatterjee K, et al. 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008;52:e1-142.
6. Varadarajan P, Kapoor N, Bansal RC, et al. Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006;82:2111-5.
7. Roques F, Nashef SA, Michel P, et al. Risk factors and outcome in European cardiac surgery: analysis of the EuroSCORE multinational database of 19030 patients. Eur J Cardiothorac Surg 1999;15:816-22.
8. Roques F, Michel P, Goldstone AR, et al. The logistic EuroSCORE. Eur Heart J 2003;24:881-2.
9. Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90.
10. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system. Circ Cardiovasc Interv 2008;1:167-75.
11. Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76.
12. Federal Institute for Medicinal Products and Medical Devices. German Drug Law (Arzneimittelgesetz - AMG) of the Federal Republic of Germany. http://www.gesetze-im-internet.de/gcp-v/BJNR208100004.html (accessed 9 Feb 2009). 9 A.D.
13. Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: the task force on the Management of valvular heart disease of the European society of cardiology. Eur Heart J 2007;28:230-68. (Pubitemid 46276943)
14. Baumgartner H, Hung J, Bermejo J, et al. Echocardiographic assessment of valve stenosis: EAE/ASE recommendations for clinical practice. J Am Soc Echocardiogr 2009;22:1-23.
15. Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000;343:611-17.
16. Ramaraj R, Sorrell VL. Degenerative aortic stenosis. BMJ 2008;336:550-5.
17. Rosenhek R, Klaar U, Schemper M, et al. Mild and moderate aortic stenosis. Natural history and risk stratification by echocardiography. Eur Heart J 2004;25:199-205.
18. Chizner MA, Pearle DL, deLeon AC Jr. The natural history of aortic stenosis in adults. Am Heart J 1980;99:419-24.
19. Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988;9(Suppl E):57-64.
20. Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982;66:1105-10.
21. Iivanainen AM, Lindroos M, Tilvis R, et al. Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996;78:97-101. (Pubitemid 26255461)
22. Himbert D, Descoutures F, Al-Attar N, et al. Results of Transfemoral or Transapical Aortic Valve Implantation Following a Uniform Assessment in High-Risk Patients With Aortic Stenosis. J Am Coll Cardiol 2009;54:303-11.
23. Pai RG, Kapoor N, Bansal RC, et al. Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006;82:2116-22.